Integrated BioPharma, Inc. INBP
0.17 USD 0.00 (+0.00%)
At closeNov 11, 2026, 4:00 PM EST
0.17375 Day range 0.17375
0.14 52-week range 0.42
- YTD
- -52.78%
- 1 year
- -45.16%
News
accessnewswire.com Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026 HILLSIDE, NJ / ACCESS Newswire / September 25, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30,…
accessnewswire.com Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 HILLSIDE, NJ / ACCESS Newswire / May 8, 2026 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2026. Revenue for the…
accessnewswire.com Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 HILLSIDE, NJ / ACCESS Newswire / February 11, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025. Revenue…
globenewswire.com Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions LAUPHEIM, Germany and MARTINSRIED, Germany and MUNICH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for…
accessnewswire.com Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 HILLSIDE, NJ / ACCESS Newswire / November 10, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2025. Revenue…
accessnewswire.com Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30,…
accessnewswire.com Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 HILLSIDE, NJ / ACCESS Newswire / May 14, 2025 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2025. Revenue for the…
accessnewswire.com Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 HILLSIDE, NJ / ACCESS Newswire / February 13, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2024. Revenue…
accesswire.com Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 HILLSIDE, NJ / ACCESSWIRE / November 13, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2024. Revenue for…
accesswire.com Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024.…
accesswire.com Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024. Revenue for each of…
accesswire.com Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for…
accesswire.com Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023 HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for…
accesswire.com Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023 HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023.…
prnewswire.com OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX:…
seekingalpha.com Integrated BioPharma: Strong Growth For Less Than A 5 P/E The company's quarterly results saw revenue increase 33% and earnings increase 233% to $0.04 per share. With a current share price of about $0.60, the stock is trading for under 4x trailing earnings.
benzinga.com Stocks That Hit 52-Week Highs On Friday 
benzinga.com Stocks That Hit 52-Week Highs On Wednesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday